drugset / Trial / NCT06648304
Evaluate the Efficacy and Safety of TTYP01 Tablets in the Treatment of Acute Ischemic Stroke
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study is designed as a multi-center, randomized, double-blind, parallel, placebo-controlled trial to evaluate the efficacy and safety of TTYP01 tablets in the treatment of acute ischemic stroke.
Timeline
- Start
- 2023-04-25
- Primary completion
- 2024-06-17
- Completion
- 2024-06-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TTYP01 | Unknown | 60 mg | — |